A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients

This is a 2-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients.

Inclusion Criteria:

• Obese men and nonpregnant women at least 18 years of age with a specific body mass index (height and weight ratio) required by the study

Exclusion Criteria:

• Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)